Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience ; day:16 ; month:7 ; year:2024 ; pages:1-3
Journal of nephrology ; (16.7.2024), 1-3
- Urheber
-
Busutti, Marco
Maritati, Federica
Borelli, Greta
Bini, Claudia
Corradetti, Valeria
Cuna, Vania
Abenavoli, Chiara
Provenzano, Michele
Ravaioli, Matteo
La Manna, Gaetano
Comai, Giorgia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40620-024-02005-7
- URN
-
urn:nbn:de:101:1-2410090958272.122091369983
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Busutti, Marco
- Maritati, Federica
- Borelli, Greta
- Bini, Claudia
- Corradetti, Valeria
- Cuna, Vania
- Abenavoli, Chiara
- Provenzano, Michele
- Ravaioli, Matteo
- La Manna, Gaetano
- Comai, Giorgia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis